(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2R)-2-methylbutanoate(CAS: 79952-44-6)
![(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2R)-2-methylbutanoate (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2R)-2-methylbutanoate](https://cnstatic.chemtradehub.com/structs/799/79952-44-6-cc45.webp)
CAS号
相关产品
其他供应商提供的 (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2R)-2-methylbutanoate
基本信息
分子式
C24H36O5
分子量
404.55 g/mol
Physical Properties
熔点
108-110?C
密度
1.12
化学标识符
SMILES
CC[C@@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
InChIKey
PCZOHLXUXFIOCF-YPQFMRJXSA-N
数据库引用
MDL号
MFCD21363830
常见问题
EPI-洛伐他汀是一种化学合成的降胆固醇药物,主要用于治疗高胆固醇血症和混合型血脂异常。
EPI-洛伐他汀主要用于降低血液中的低密度脂蛋白胆固醇(LDL-C),同时提高高密度脂蛋白胆固醇(HDL-C)水平,减少心血管疾病的风险。
EPI-洛伐他汀较为安全,但使用时需注意可能的副作用,如肝功能异常、肌肉疼痛等。应在医生指导下使用,并定期检查肝功能和肌酸激酶水平。
EPI-洛伐他汀应储存在阴凉、干燥处,避免直射阳光。储存温度应控制在15-30℃之间,远离儿童和宠物。储存容器需密封,避免与空气接触。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序
联系信息
邮箱
info@tonichempharma.com

![4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]-1-butanol](https://cnstatic.chemtradehub.com/structs/870/870765-38-1-59fa.webp)

![{2,3-Dichloro-4-[2-(hydroxymethyl)butanoyl]phenoxy}acetic acid](https://cnstatic.chemtradehub.com/structs/957/95772-54-6-7807.webp)

![(1R,3S,7R,8R,8aS)-8-{2-[(2R,4S)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl 2,2-dimethylbutanoate](https://cnstatic.chemtradehub.com/structs/799/79902-62-8-7614.webp)
![Ethyl 8-chloro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate](https://cnstatic.chemtradehub.com/structs/787/78756-33-9-8eaa.webp)
![[6-(Difluoromethoxy)-1-methyl-1H-benzimidazol-2-yl][(3,4-dimethoxy-2-pyridinyl)methyl]sulfoniumolate](https://cnstatic.chemtradehub.com/structs/721/721924-06-7-01d4.webp)


![(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2R)-2-methylbutanoate — 上海源叶生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce9f132b2de6e8e95a48fe/67ce9f132b2de6e8e95a48fe-logo.webp)
![(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2R)-2-methylbutanoate — 上海绩祥生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce6f4d2b2de6e8e95a45bf/67ce6f4d2b2de6e8e95a45bf-logo.webp)
![(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2R)-2-methylbutanoate — 湖北扬信医药科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cded3957537e5c8069af88/67cded3957537e5c8069af88-logo.webp)
![(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2R)-2-methylbutanoate — 北京百灵威科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cde31e57537e5c8069aebf/67cde31e57537e5c8069aebf-logo.webp)
![(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2R)-2-methylbutanoate — 深圳振强生物技术有限公司](https://cnstatic.chemtradehub.com/suppliers/67cec9142b2de6e8e95a51e7/67cec9142b2de6e8e95a51e7-logo.webp)